°Ë»ö
ä¿ë
Á¤º¸
    ¾à»çµé ¾Ë·ç¹Ì´½ µî ÀϺΠÁß±Ý¼Ó ³ëÃâ
    ±â»çÀÔ·Â : 01.05.23 22:01:00
    0 °¡
    ÇÃÄ£Ãß°¡
    ½´ÆÛ¶óÀÌÇÁ³×Æ®¡¤ENÅ×Å©³î·ÎÁö, ¸ð¹ß¹Ì³×¶ö Å×½ºÆ® °á°ú



    °³±¹¾à»çµéÀÌ WHO(¼¼°èº¸°Ç±â±¸)ÀÇ ±âÁØÄ¡ ÀÌ»óÀÇ ¾Ë·ç¹Ì´½¡¤¹Ù·ý µî ÀϺΠÁ߱ݼӿ¡ ¿À¿°µÅ ÀÖ´Â °ÍÀ¸·Î Á¶»çµÆ´Ù.

    ÀǾàÀü¹® Á¤º¸Åë½Å À¯Åë Çù¾÷üÀÎ '½´ÆÛ¶óÀÌÇÁ³×Æ®'¿Í ¸ð¹ß¼Ó Áß±Ý¼Ó Àü¹® ÃøÁ¤È¸»çÀÎ 'ENÅ×Å©³î·ÎÁö'°¡ ¾à»ç 40¸í(³²ÀÚ 8¸í, ¿©ÀÚ 32¸í)À» ´ë»óÀ¸·Î ¸ð¹ß ¹Ì³×³¯ Å×½ºÆ®¸¦ ½Ç½ÃÇÑ °á°ú ¾Ë·ç¹Ì´½ÀÌ WHO ±âÁØÄ¡ÀÎ 7ppmº¸´Ù ³ôÀº Æò±Õ 8.37ppmÀÌ °ËÃâµÆ´Ù°í 23ÀÏ ¹àÇû´Ù.

    ¶ÇÇÑ ¹Ù·ýÀº Æò±Õ 2.21ppm(±âÁØÄ¡ 1.5ppm), ¼öÀº 1.33ppm(±âÁØÄ¡ 1ppm) µîÀÌ °ËÃâµÆ´Ù.

    ±×·¯³ª ¾ÈƼ¸óÀº 0.04ppm(±âÁØÄ¡ 0.6ppm), ºñ¼Ò 0.14ppm(1ppm), Ä«µå´½ 0.02ppm(1.5ppm), ³³ 0.54ppm(4ppm), ºñ½º¹«½º 0.7ppm(1ppm), ¿ì¶ó´½ 0.11ppm(1ppm) µîÀ¸·Î ±âÁØÄ¡º¸´Ù ³·°Ô ³ªÅ¸³µ´Ù.

    À̿Ͱü·Ã ½´ÆÛ¶óÀÌÆ®ÃøÀº "È¥ÀÚ ±Ù¹«ÇÏ´Â ¿©¾à»çÀÇ °æ¿ì ¹Ù·ý¿¡ ¸¹ÀÌ ¿À¿°µÅ ÀÖÀ¸¸ç, ¹Ù·ý¿¡ ¿À¿°µÈ ¾à»çÀÇ °æ¿ì Ä®½·, ¸¶±×³×½·ÀÇ Èí¼öÀúÇØ¸¦ ¹Þ°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³ª °ñ´Ù°ñÁõÀ» ÀǽÉÇØ º¼¼ö ÀÖ´Ù"°í ¹àÇû´Ù.

    ¶ÇÇÑ "¾à±¹¿¡¼­ ¿À·¡±â°£ ±Ù¹«ÇÑ °í·ÉÀÇ ¾à»çÀϼö·Ï ¹Ù·ýÀÇ ¿À¿°µµ°¡ ³ô¾Æ Á¶Á¦½Ç ȯ°æ°ú ¹Ù·ý°úÀÇ »ó°ü°ü°è¸¦ ÀǽÉÇØ º¼¼ö ÀÖ´Ù"¸ç "¾Ë·ç¹Ì´½ÀÇ ³óµµ´Â ÀþÀº 20, 30´ë ¾à»ç¿¡°Ô ³ô°Ô ³ªÅ¸³ª ½Ä»ýȰ¹®È­¿Í »ó°ü°ü°è°¡ ÀÖÀ½À» º¸¿©ÁÖ´Â °Í"À̶ó°í ¼³¸íÇß´Ù.
    X
    AD
    Á¾¼Ò¼¼ °£Æí°è»ê GO À̺¥Æ®Âü¿© ¡æ
    ±èÁø°­ ±âÀÚ(kjk1223@dailypharm.com)
    ±ÛÀÚÅ©±â ¼³Á¤
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    • [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â
    • ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    • MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â
    • º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â
    • °­¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    • ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â
    • Çâ³² °øÀå Á¦Á¶°ü¸®¾à»ç °æ·Âä¿ë ¹Ù·Î°¡±â
    • ¼­¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â
    • Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â
    • [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â
    • [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â
    • Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â
    • º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â
    • Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â
    • RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â
    0/300
     
    ¸ÞÀϺ¸³»±â
    ±â»çÁ¦¸ñ : ¾à»çµé ¾Ë·ç¹Ì´½ µî ÀϺΠÁß±Ý¼Ó ³ëÃâ